Growth Metrics

Lemaitre Vascular (LMAT) Operating Margin (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Operating Margin for 16 consecutive years, with 51.65% as the latest value for Q4 2025.

  • On a quarterly basis, Operating Margin fell 7472.0% to 51.65% in Q4 2025 year-over-year; TTM through Dec 2025 was 6.33%, a 1744.0% decrease, with the full-year FY2025 number at 6.33%, down 1744.0% from a year prior.
  • Operating Margin was 51.65% for Q4 2025 at Lemaitre Vascular, down from 33.27% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 33.27% in Q3 2025 to a low of 51.65% in Q4 2025.
  • A 5-year average of 17.97% and a median of 21.05% in 2025 define the central range for Operating Margin.
  • Biggest YoY gain for Operating Margin was 929bps in 2025; the steepest drop was -7472bps in 2025.
  • Lemaitre Vascular's Operating Margin stood at 21.01% in 2021, then decreased by -19bps to 17.01% in 2022, then grew by 23bps to 20.88% in 2023, then rose by 10bps to 23.07% in 2024, then crashed by -324bps to 51.65% in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Operating Margin are 51.65% (Q4 2025), 33.27% (Q3 2025), and 25.13% (Q2 2025).